<DOC>
	<DOC>NCT01908764</DOC>
	<brief_summary>The purpose of this study is to describe the pharmacokinetics of AL-60371 otic suspension following two posologies of bilateral ototopical doses in pediatric subjects immediately after bilateral tympanostomy tube surgery.</brief_summary>
	<brief_title>Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>Requires bilateral myringotomy and tympanostomy tube insertion; Provides informed consent (parent/legal guardian); Signs assent form where applicable (subject); Accompanied by parent/legal guardian at each visit; Other protocoldefined inclusion criteria may apply. Menarcheal females; Current or recent history of any disease which, in the opinion of the Principal Investigator, may place the subject at risk or interfere with study; Use of excluded medications within one week prior to surgery and for the duration of the study; Requires another surgical procedure in addition to the myringotomy; Clinically relevant otic condition which, in the opinion of the Principal Investigator, would preclude the safe administration of the study medication; Participation in any other investigational study within 30 days before entry into this study or along with this study; Known or suspected allergy or hypersensitivity to any active or inactive ingredient in the test article; Other protocoldefined exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>ear tubes</keyword>
	<keyword>tympanostomy tubes</keyword>
	<keyword>Otitis Media at the time of Tympanostomy Tube surgery</keyword>
	<keyword>OMTT</keyword>
</DOC>